imipramine has been researched along with Leishmaniasis in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The parasite enzyme trypanothione reductase has been used as a target for rational drug design against trypanosomiasis and leishmaniasis in a number of laboratories." | 4.80 | Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-leishmanial drug leads. ( Austin, SE; Douglas, KT; Khan, MO, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, SE | 1 |
| Khan, MO | 1 |
| Douglas, KT | 1 |
1 review available for imipramine and Leishmaniasis
| Article | Year |
|---|---|
Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-leishmanial drug leads.
Topics: Adrenergic Uptake Inhibitors; Antiparasitic Agents; Drug Design; Enzyme Inhibitors; Glutathione; Imi | 1999 |